1
EXHIBIT 99.2
SELECTED CONSOLIDATED FINANCIAL DATA
The following selected consolidated financial data are derived from the audited
consolidated financial statements of Aurora Biosciences Corporation and should
be read in conjunction with the supplemental consolidated financial statements
and accompanying notes and "Management's Discussion and Analysis of Financial
Condition and Results of Operations" included elsewhere in this Current Report.
PERIOD FROM
NINE MONTHS MAY 8, 1995
ENDED SEPTEMBER 30,(1) YEARS ENDED DECEMBER 31, (INCEPTION) TO
----------------------- ---------------------------------------------- DECEMBER 31,
2000 1999 1999(1) 1998(1) 1997 1996 1995
-------- -------- -------- -------- -------- -------- --------------
STATEMENT OF OPERATIONS
DATA:
(in thousands, except
per share amounts)
Revenue $ 47,287 $ 30,635 $ 50,521 $ 26,558 $ 14,908 $ 2,217 $ --
Operating expenses:
Cost of revenue 25,943 19,833 27,942 23,814 6,983 -- --
Research and development 10,415 9,299 11,593 17,146 5,406 4,396 366
Selling, general and
administrative 11,115 8,846 11,933 6,104 3,679 1,275 46
-------- -------- -------- -------- -------- -------- ----------
Total operating expenses 47,473 37,978 51,468 47,064 16,068 5,671 412
-------- -------- -------- -------- -------- -------- ----------
Loss from operations (186) (7,343) (947) (20,506) (1,160) (3,454) (412)
Interest income 6,481 1,124 1,546 2,444 1,793 580 --
Interest expense (513) (519) (691) (645) (346) (59) --
-------- -------- -------- -------- -------- -------- ----------
Income (loss) before
income taxes 5,782 (6,738) (92) (18,707) 287 (2,933) (412)
Income taxes (510) -- (117) -- (20) -- --
-------- -------- -------- -------- -------- -------- ----------
Net income (loss) $ 5,272 $ (6,738) $ (209) $(18,707) $ 267 $ (2,933) $ (412)
======== ======== ======== ======== ======== ======== ==========
Basic income (loss)
per share $ 0.27 $ (0.40) $ (0.01) $ (1.15) $ 0.03 $ (3.86) $(5,146.59)
======== ======== ======== ======== ======== ======== ===========
Diluted income (loss)
per share $ 0.24 $ (0.40) $ (0.01) $ (1.15) $ 0.02 $ (3.86) $(5,146.59)
======== ======== ======== ======== ======== ======== ==========
Shares used in computing:
Basic income (loss)
per share 19,677 16,932 17,019 16,336 8,970 760 <1
======== ======== ======== ======== ======== ======== ==========
Diluted income (loss)
per share 22,111 16,932 17,019 16,336 15,423 760 <1
======== ======== ======== ======== ======== ======== ==========
DECEMBER 31,
SEPTEMBER 30, -------------------------------------------------------------------------
2000(1) 1999(1) 1998(1) 1997 1996 1995
------------- --------- --------- --------- --------- ---------
BALANCE SHEET DATA:
(in thousands)
Cash, cash equivalents and
investments $ 106,721 $ 36,733 $ 28,082 $ 48,906 $ 13,167 $ 11
Total assets 151,395 64,007 51,032 63,036 17,515 115
Capital lease obligations,
less current portion 3,949 4,343 4,788 3,422 1,111 --
Accumulated deficit (16,722) (21,994) (21,785) (3,078) (3,345) (412)
Total stockholders' equity 125,713 40,413 37,595 54,364 15,184 (412)
Note:
(1) Data includes amounts for Quorum Sciences (see Note 1 of the Notes to
the Supplemental Consolidated Financial Statements).